130 related articles for article (PubMed ID: 6331934)
1. Type III membranoproliferative glomerulonephritis: long-term clinical and morphologic evaluation.
Strife CF; Jackson EC; McAdams AJ
Clin Nephrol; 1984 Jun; 21(6):323-34. PubMed ID: 6331934
[TBL] [Abstract][Full Text] [Related]
2. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
Strife CF; McEnery PT; McAdams AJ; West CD
Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
[TBL] [Abstract][Full Text] [Related]
3. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
Braun MC; West CD; Strife CF
Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
[TBL] [Abstract][Full Text] [Related]
4. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
5. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
Abreo K; Moorthy AV
Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
[TBL] [Abstract][Full Text] [Related]
6. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
Strife CF; McAdams AJ; West CD
Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
[TBL] [Abstract][Full Text] [Related]
8. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.
McEnery PT; McAdams AJ; West CD
Clin Nephrol; 1980 Mar; 13(3):117-24. PubMed ID: 7379361
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of change with time of glomerular morphology in membranoproliferative glomerulonephritis: a serial biopsy study of 33 cases.
Taguchi T; Bohle A
Clin Nephrol; 1989 Jun; 31(6):297-306. PubMed ID: 2665991
[TBL] [Abstract][Full Text] [Related]
11. Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study.
Lamb V; Tisher CC; McCoy RC; Robinson RR
Lab Invest; 1977 Jun; 36(6):607-17. PubMed ID: 325295
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and glomerular immunofluorescence of renal biopsies from children with nephrotic syndrome due to minimal change disease and two variants of mesangial proliferative glomerulonephritis.
Hui A; Poucell S; Thorner P; Rance CP; Baumal R
Int J Pediatr Nephrol; 1984 Mar; 5(1):5-10. PubMed ID: 6370883
[TBL] [Abstract][Full Text] [Related]
13. [Membranoproliferative glomerulonephritis. Variability of a morphologically definable disease].
Anders D; Bläker F; Gekle D; Kehrberg H
Klin Padiatr; 1982; 194(3):173-81. PubMed ID: 7132223
[TBL] [Abstract][Full Text] [Related]
14. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
Davis AE; Schneeberger EE; Grupe WE; McCluskey RT
Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
[TBL] [Abstract][Full Text] [Related]
15. Histological, ultrastructural and immunofluorescence studies in membranoproliferative glomerulonephritis.
Nagi AH
J Pathol; 1972 Mar; 106(3):151-4. PubMed ID: 4114030
[No Abstract] [Full Text] [Related]
16. Mesangiocapillary glomerulonephritis: a long-term study of 40 cases.
Swainson CP; Robson JS; Thomson D; MacDonald MK
J Pathol; 1983 Dec; 141(4):449-68. PubMed ID: 6363655
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological studies in human renal disease. V. Histological, immunohistological and electron microscopic finding in follow-up biopsies.
Beregi E; Varga I
Acta Med Acad Sci Hung; 1973; 30(4):251-64. PubMed ID: 4600053
[No Abstract] [Full Text] [Related]
18. [Membranoproliferative glomerulonephritis. Morphological observations and considerations on pathogenesis].
Anders D
Immun Infekt; 1982 Nov; 10(6):219-29. PubMed ID: 6764212
[TBL] [Abstract][Full Text] [Related]
19. Regression of membranoproliferative glomerulonephritis type II (dense deposit disease): observations in six children.
McEnery PT; McAdams AJ
Am J Kidney Dis; 1988 Aug; 12(2):138-46. PubMed ID: 3400634
[TBL] [Abstract][Full Text] [Related]
20. Experimental infections with African Trypanosomes. VI. Glomerulonephritis involving the alternate pathway of complement activation.
Nagle RB; Ward PA; Lindsley HB; Sadun EH; Johnson AJ; Berkaw RE; Hildebrandt PK
Am J Trop Med Hyg; 1974 Jan; 23(1):15-26. PubMed ID: 4204023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
